Live symbol workspace

TXG market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $22.33

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$21.21

Resistance

$23.45

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$22.33

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

— 0.0 pts vs previous week

Avg confidence across 7 calls in the last 7 days

What sources say

No news-sourced AI calls in the last 30 days.

Insider Trading

Insider	Role	Date	Type	Value
Saxonov Serge	Chief Executive …	Jun 22 '26	Sale	1033269.0
SULIMAN SHEHNAAZ	Director	Jun 16 '26	Sale	186756.0
Shehnaaz Suliman	Affiliate	Jun 16 '26	Proposed Sale	184395.0
Saxonov Serge	Chief Executive …	May 22 '26	Sale	444224.0
Saxonov Serge	Chief Executive …	May 26 '26	Sale	264833.0
Hindson Benjamin J.	See Remarks	May 22 '26	Sale	283399.0
Taich Adam	Chief Financial …	May 22 '26	Sale	369018.0
Serge Saxonov	Director, CEO	May 26 '26	Proposed Sale	964202.0
Saxonov Serge	Officer	May 22 '26	Proposed Sale	442957.0
Hindson Benjamin J.	Officer	May 22 '26	Proposed Sale	232732.0

Source: FinViz — Data may be delayed

Technical Observations

Refreshing technical observations from FinViz...

TXG News Intelligence (1 articles)

AI-curated news influencing TXG price, sentiment, and trend

Explore All TXG News with AI Analysis

Economy

3 months, 1 week ago

Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know

A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial …

Impact on TXG: The decline in these stocks, particularly in the healthcare and biotech sectors, …

Shares of Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna plummeted in the afternoon session … High (80%)

View full analysis →

Yahoo Finance 80% confidence